Abstract With the growing interest in the field of proteomics, the amount of publicly available proteome resources has also increased dramatically. This means that there are many useful resources available for almost all aspects of a proteomics experiment. However, it remains vital to use the right resource, for the right purpose, at the right time. This review is therefore meant to aid the reader in obtaining an overview of the available resources and their application, thus providing the necessary background to choose the appropriate resources for the experiment at hand. Many of the resources are also taking advantage of so-called crowdsourcing to maximize the potential of the resource. What this means and how this can improve future experiments will also be discussed. The text roughly follows the steps involved in a proteomics experiment, starting with the planning of the experiment, via the processing of the data and the analysis of the results, to the community-wide sharing of the produced data.
Background
The process of crowdsourcing refers to the outsourcing of tasks to a distributed group of people or communities, but unlike ordinary outsourcing the task or problem is here outsourced to an undefined public rather than to a specific group of people. Crowdsourcing is not a novel concept and has been employed in numerous types of situations, with perhaps the best known example being Wikipedia. The approach has become increasingly common with the global spread of the internet. While crowdsourcing may not be a commonly used term in the proteomics community, significant parts of key proteomics resources have already been crowdsourced from the scientific community for a long time. This review will highlight the best examples and show how the use of public resources can lead to better experiments.
The most commonly employed technique in proteomics today is mass spectrometry (MS). Usually, MS-based proteomics is carried out according the bottom-up strategy, where the proteins to be analyzed are first proteolytically cleaved in vitro into smaller pieces called peptides, that are further fragmented by the MS instrument into fragment ions, resulting in MS/MS spectra (Aebersold and Mann 2003) . There are two general flavors of this type of MS-based proteomics experiment: (i) discovery-oriented experiments that try to identify (and increasingly, try to quantify) all the proteins in a sample, and (ii) targeted experiments that focus on the analysis of specific signature peptides for a limited number of proteins of interest in a sample.
Despite the overall similarity in methods employed between these two flavors of bottom-up proteomics, it is important to keep in mind that their properties are very different, thus requiring unique experimental workflows and bioinformatics pipelines for each. Fortunately, a vast amount of publicly available resources exist that can guide the user on his/her way. In this review, we will cover the most important relevant resources and show when and how they ought to be applied to maximize the potential of the analysis, see Fig. 1 .
Note that we have decided to focus on resources that help the user with specific tasks required during an experiment. Software packages aiming at providing a complete pipeline are outside the scope of this review and will thus not be covered. The same is true for the long list of possible proteomics search engines. Finally, where possible, we will focus on the resources employing crowdsourcing, highlighting how these resources are especially important to get the most out of the large amount of proteomics data being produced every year.
From ideas to experiments
Perhaps the most important part of a proteomics experiment (or indeed any experiment) is the planning of the experiment. This step, which can also be referred to as experimental design, is paramount to obtaining a useful outcome. Shortcomings at this stage are very difficult, if not impossible, to correct downstream in the workflow, further emphasizing the critical relevance of this stage. Even though this simple truth ought to be obvious, it is not uncommon to encounter experiments where small changes in the design could have significantly increased the value of the experiment. In some cases, a planning-phase analysis may even save one the trouble of doing experiments, if it becomes clear a priori that they will have a very low probability of success, for instance if too few replicates are available to obtain a reasonable likelihood of achieving significant results. It is therefore essential to plan an experiment in advance, and it can be very helpful to consult relevant resources in this initial phase.
Besides the obvious caveats connected to statistical considerations, such as power analysis (Levin 2011) , replicate types and numbers (Oberg and Vitek 2009) , and sample pooling (Karp and Lilley 2009 ) that affect discovery-oriented and targeted approaches alike, there are also more specific issues that relate predominantly to the planning of targeted proteomics experiments. These latter issues are the main focus of this section, since they can most readily be addressed through the judicious use of public resources. Examples include the determination of suitable peptides and transitions for a selected reaction monitoring (SRM) experiment, or the focused analysis of membrane proteins.
In targeted proteomics, as the name implies, a set of proteins of interest is typically known a priori, often as a result of a preceding discovery-oriented analysis (Gallien et al. 2011) . But even if the protein set is known in advance it can still be very useful to perform a thorough pre-analysis. The simplest form of investigation in this case would be to perform an in silico digest of the given protein, i.e., to theoretically cleave the protein into peptides using the cleavage pattern and specifics of the desired proteolytic enzyme, and list the detectable peptides as limited by one or more appropriate parameters such as sequence length or mass, sequence composition, number of missed cleavages, or theoretical iso-electric point (pI). Such in silico digestion and in-line peptide filtering is readily offered by several freely available database processing tools and proteomics software libraries Reisinger and Martens 2009; Colinge et al. 2006; Barsnes et al. 2011 ). This straightforward analysis yields indications of the detectable areas of the protein sequence, and the expected number of peptides that can be successfully targeted. Of course, if the objective of the study is the detection of a specific post-translational modification or in vivo cleavage, it can be immediately verified whether the sequence region of interest yields any detectable peptides, see Fig. 2 . If the chosen protease should not yield the desired peptide(s), it is then an exceedingly simple exercise to try another protease and evaluate the outcome. If multiple targets are considered, perhaps a combination of proteases (albeit employed in parallel) could even be considered (Swaney et al. 2010) . Performing in silico digests is, however, not an exact science. First of all, cleavage may not always occur where expected (Hamady et al. 2005; Thiede et al. 2000; Yen et al. 2006) , and may even occur where it is not expected (Rodriguez et al. 2008 therefore still benefit bottom-up proteomics approaches (Siepen et al. 2007 ). It should also be underlined that the detectability of a peptide is specific to the mass spectrometry protocol, and that the results are therefore not directly transferable between protocols. Such an in silico digest can then be complemented by resources that provide so-called proteotypic peptides (Craig et al. 2005) , such as PeptideAtlas (Desiere et al. 2006) or GPMDB (Craig et al. 2004) , although the actual overlap in proteotypic peptides between these resources is incomplete. Computational methods have been proposed to predict prototypic peptides, e.g., (Mallick et al. 2007 ), but they have been shown to function quite poorly outside of their (typically limited) initial training conditions (Mueller et al. 2008 ), indicating that caution should be used in relying only on purely predicted entries.
It is not just a predefined set of peptides that is selected for in targeted proteomics, however, but rather a combination of fragment ion masses and peptide precursor mass for each targeted peptide. Such a precursor and fragment ion pair is commonly referred to as a transition, and such transitions form the core of the increasingly popular selected reaction monitoring (SRM) approach in targeted proteomics (Lange et al. 2008b) . In this technique, targeting the correct transitions is of equal importance as targeting the right peptides. Various resources for predicting good transitions have been created, and these represent either predicted optimally detectable transitions (MacLean et al. 2010; Abbatiello et al. 2010; Brusniak et al. 2011) , or unique transitions (Helsens et al. 2012) , i.e., transitions that are unlikely to be contaminated by overlapping signals from other, non-targeted peptides ). Databases of known, experimentally observed transitions are also available (Domon and Aebersold 2006; Lange et al. 2008a; Deutsch et al. 2008; Craig et al. 2004) , and are likely to become increasingly important over time as more of these analyses are ran. Importantly, work on standardizing an exchange format for transitions has also progressed , and an international initiative to find transitions for all human proteins has been initiated as a part of the Human Proteome Organization-Human Proteome Project (HUPO-HPP) (The call of the human proteome 2010; Nilsson et al. 2010) . Interestingly, a rather complete library of synthetic peptides has already been completed for yeast (Picotti et al. 2010) . It is important to consider that good transitions are often specific to an instrument and the experimental settings used, i.e., a good transition for one experimental setup might not be a good transition when using a different experimental setup. To some extent this can be related to the observed instrument-dependent peptide fragmentation Sherwood et al. 2009 ), although it has been reported that top-ranking peaks are more readily transferable (Sherwood et al. 2009 ).
To efficiently reuse experimental data, it is important to filter the data according to the requirements (Foster et al. 2011) , and to understand the experimental setup in sufficient detail. This is not always straightforward, however, since even the protocol descriptions in the metadata-rich PRIDE database (Vizcaíno et al. 2010 ) are often lacking in detail. Furthermore, data quality is not necessarily correlated with annotation quality. This situation highlights the importance of adhering to minimum information guidelines such as MIAPE (Taylor 2006) , one of the main goals of both the ProDaC project (Eisenacher et al. 2009 ) and the HUPO-PSI Vizcaino et al. 2007) .
It is of course always possible that a particular protein of interest turns out to be very hard to target, despite the best efforts at finding suitable candidate peptides and transitions. If the study objective is not the specific characterization of a cleavage or post-translational modification on that particular protein, a possible alternative may be to find related proteins and target these instead. This can be achieved by searching for interaction partners in IntAct (Kerrien et al. 2012) , STRING (Szklarczyk et al. 2011 ) or DAVID (Huang da et al. 2009 ), or by looking for proteins in the same pathway in Reactome (Matthews et al. 2009) or KEGG (Kanehisa et al. 2012) .
From acquired data to processed results
Once the experiment has been performed, the data need to be processed into peptide identifications (and quantifications). Since the actual output of an MS experiment is a set of MS/MS spectra, the first step typically consists of identifying the origin of these spectra, i.e., match spectra to peptides. While various options exist for this goal [including de novo sequencing (Frank et al. 2007; Ma and Johnson 2012) and tag-based approaches (Tabb et al. 2003 (Tabb et al. , 2008 ], database searching is by far the most common spectrum identification method. Here, acquired spectra are matched to a set of known spectra to find the best match Fig. 2 Performing a pre-experiment in silico digest can provide valuable insight into the theoretically coverable areas of a given protein sequence. a In this simple example, the goal is to detect the two phosphorylations indicated. b Performing an in silico digest tells us that, assuming the given enzyme properties, some areas of the protein sequence most likely can be detected (green), while others cannot (orange). From this, we can infer that performing an experiment targeting the second modification will (most likely) be of little value using the selected protease and thereby transitively assign identification. There are two types of databases that can be used for this purpose: protein sequence databases and spectral databases. The former are used to derive relatively unsophisticated in silico theoretical fragmentation spectra (Cottrell 1994; Eng et al. 1994; Yates et al. 1995; Geer et al. 2004; Fenyo and Beavis 2003) , while the latter contain previously identified experimental MS/MS spectra (Lam 2011) (NIST: http://peptide.nist.gov) and have been shown to outperform sequence database searching under optimal conditions . One can also generate a realistic spectral library from a sequence database using detailed MS/MS spectrum prediction (Zhang 2004 (Zhang , 2005 Yen et al. 2009 Yen et al. , 2011 , but this is a more complicated process. When searching a database, it is of course exceedingly important to use the right database. Selecting a database that does not contain the protein in question will result in the protein going undetected, while choosing a database that contains too much data can result in a large amount of false positives Everett et al. 2010; Na et al. 2012; Bern and Kil 2011) , similar to the effect encountered when using error-tolerant searches (Creasy and Cottrell 2002) . Numerous sequence databases are available, ranging from small home-grown databases to the centralized and well-annotated species-wide databases like UniProt (UniProt Consortium 2010), Ensembl (Flicek et al. 2011 ) and NCBI nr (Pruitt et al. 2007 ).
In choosing a database, a choice has therefore to be made between completeness, reliability and redundancy of the information contained in these systems. It is, however, possible to compare search databases on this basis using a very simple set of metrics: define the number of identifiable tryptic peptides with one allowed missed cleavage in each database as the database size, define the number of unique such peptides as the database information, and then calculate the information ratio as the ratio of database information over database size. The results are given for several popular human sequence databases in Fig. 3 . Note that bigger databases typically have larger information content, but that the information ratio does not scale very well. This indicates that smaller databases tend to be more compact and efficient, and that larger databases are more redundant. This is expected, since the larger databases (for human sequences at least) achieve their size growth by including splice isoforms that share a substantial part of their sequence, and therefore many of their tryptic peptides.
It is of note that the International Protein Index (IPI) (Kersey et al. 2004 ), one of the most popular proteomics Fig. 3 Plot illustrating the database content and database information (points, left axis) and derived information ratio (bars, right axis) for six popular databases in the field of proteomics. Note that IPI has been discontinued on 27 September 2011. See main text for details sequence databases, has been discontinued in September 2011. The effect that this has to the proteomics community has been examined in detail in two recent papers (Griss et al. 2011a, b) where it was also shown that UniProt now provides directly comparable alternatives, an observation that is also evident for human sequences from Fig. 3 , where both UniProt and Ensembl are seen to closely resemble IPI.
The information in a sequence database need not necessarily be taken as is, however. Indeed, further processing can dramatically extend the reach of a sequence database and correspondingly increase the number of relevant identifications, by performing serial differential enzymatic digestion (Van Damme et al. 2005) , amino-or carboxyterminal ragging (Gevaert et al. 2003) , sequence-based subset selection (Gevaert et al. 2002 (Gevaert et al. , 2004 , or to create and add decoy sequences . Various tools exist that greatly facilitate such operations Reisinger and Martens 2009; Reidegeld et al. 2008 ).
As mentioned above, however, the use of arbitrarily large databases [or simulating them, through second-pass, error-tolerant, or multi-stage searches (Tharakan et al. 2010) ] is wrought with peril. It becomes relatively easy to severely underestimate false positive rates (Creasy and Cottrell 2002; Everett et al. 2010; Colaert et al. 2011) and it can strongly complicate the assignment of peptides to proteins Nesvizhskii and Aebersold 2005) . The best possible database should therefore be both comprehensive as well as compact, and should be in silico adapted to the specifics of the protocol.
From proteins to knowledge
Once a set of peptides is identified, and a set of proteins is successfully inferred from these, it is often useful to obtain as much information as possible about these proteins. This transition from results to knowledge is of course extensively reliant on the large amount of available annotation resources. These include, but are not limited to, gene ontology annotations (Binns et al. 2009 ), pathways (Matthews et al. 2009 ), interactions (Szklarczyk et al. 2011 ), functional annotations (Huang da et al. 2009 ), 3D structures (Villaveces et al. 2011; Prlic et al. 2005; Berman et al. 2000) and protein domain signatures (Hunter et al. 2012) . A comprehensive overview of available resources for the annotation of protein sets is provided in (Vizcaino et al. 2009 ).
To use most of these resources, however, one first has to be able to provide a protein identifier or accession number that the resource in question can understand. Note that this means that using home-made databases for peptide identification of protein inference may severely limit the downstream annotation options. Such problems are largely circumvented when a well-annotated database like UniProt is used. Incidentally, UniProt itself serves as a powerful information hub that links each protein to a plethora of external databases that span the whole spectrum of the life sciences. In those cases where the available protein identifiers are different from the ones requested by a given resource, the Protein Identifier Cross-Reference Service (PICR) can be used to perform a seamless accession number conversion (Côté et al. 2007 ). PICR provides protein identifier mappings based on 100 % sequence identity to proteins from a large number of popular databases. The mappings can be limited by database, taxonomy and activity status in the databases.
Using a single resource to annotate your data set can be very valuable, but the real value comes from combining information from different data resources. In the past, this could often be a time-consuming and laborious task, but recent developments have made this task much easier. Perhaps the most powerful tool in this context is provided by BioMart (Guberman et al. 2011; Haider et al. 2009; Kasprzyk 2011; Smedley et al. 2009; Woollard 2010 ), a distributed system that includes a large amount of databases and resources in the same, easily accessible framework. With the ability to perform queries spanning two repositories, it becomes straightforward to combine data from multiple, unrelated databases. Thanks to the inclusion in BioMart of hub databases such as UniProt and Ensembl that provide extensive cross-references, and in the case of Ensembl even span multiple levels of biological information from genome over transcriptome to proteome, BioMart queries can be extremely powerful ways to collate detailed knowledge about thousands of proteins in a few mouse clicks, see Fig. 4 . From private local data to public online data At this stage, the workflow ought to have resulted in wellannotated protein identifications and new knowledge. The next and final step is then to make this information available to the proteomics community at large. With an increased focus on the benefits of data sharing (Editors 2007 (Editors , 2008 , the development of standardized data formats such as mzML ) and mzIdentML (Eisenacher 2011) , and the development of easy-to-use conversion tools like PRIDE Converter ), the sharing of proteomics data has become a common practice. Meanwhile, the field continues to develop toward even more efficient data sharing. Notably, the ProteomeXchange consortium (Martens 2011; Orchard et al. 2011 ) was founded with the specific aim of providing a single point of submission for MS-based proteomics data, and the objective to distribute these data across all current repositories for optimal re-use and dissemination. Indeed, depositing data into a public repository is not enough; the data have to be easy to retrieve, to search, to evaluate, and to view. The PRIDE team for instance, developed the PRIDE Inspector application (Wang et al. 2012 ) specifically for this purpose. A desktop application for visualizing and performing quality assessment on mass spectrometry data contained in the PRIDE database, PRIDE Inspector, greatly improves on the old, web-based interaction with the PRIDE database, making it much more straightforward to work with the data in the repository. The remaining challenge for the field is to provide highquality, well-annotated data to the repositories, allowing today's proteomics experiments to become part of a priceless resource for the planning of future experiments. Interestingly, there is thus a strong link back to the start of this review article, where the design and planning of experiments were discussed; the public availability of quality-controlled and well-annotated proteomics data will result in ever better planned experiments, in turn leading to improved insight and knowledge from these experiments. This self-enhancing feedback loop will allow data itself to become proteomics' biggest resource, and will allow the field to become a centerstage participant in the broader life sciences.
